• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Developing a Potential New Treatment for Chronic PTSD: Ketamine Combined with Written Exposure Therapy

By: Brain & Behavior Research Foundation via GlobeNewswire
April 02, 2025 at 08:00 AM EDT

New York, April 02, 2025 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Developing a Potential New Treatment for Chronic PTSD: Ketamine Combined with Written Exposure Therapy” on Tuesday, April 8, 2025, at 2:00 pm ET. Adriana Feder, M.D., Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai will be the guest speaker, and the session will be hosted by Jeffrey Borenstein, M.D., President & CEO of the Brain & Behavior Research Foundation and host of the Emmy® nominated television series Healthy Minds.

Register Now to hear Dr. Feder’s latest research advancements on PTSD treatments.

Individuals with chronic post-traumatic stress disorder (PTSD) need effective and tolerable treatments, especially those with more severe and persistent symptoms.
Dr. Feder's research focuses on the development of novel treatment interventions for PTSD and related disorders. Her research significantly contributed to the development of ketamine as a treatment for PTSD.

In this webinar, Dr. Feder will present results of the first open-label clinical trial combining a course of repeated ketamine infusions with a brief, evidence-based psychotherapy for PTSD called written exposure therapy (WET). This pilot trial will be explained in the context of prior ketamine studies for PTSD.

About Brain & Behavior Research Foundation
The Brain & Behavior Research Foundation (BBRF) awards research grants to develop improved treatments, cures, and methods of prevention for mental illness. These illnesses include addiction, ADHD, anxiety, autism, bipolar disorder, borderline personality disorder, depression, eating disorders, OCD, PTSD, and schizophrenia, as well as research on suicide prevention. Since 1987, the Foundation has awarded more than $462 million to fund more than 5,600 leading scientists around the world. 100% of every dollar donated for research is invested in research. BBRF operating expenses are covered by separate foundation grants. BBRF is the producer of the Emmy® nominated public television series Healthy Minds with Dr. Jeffrey Borenstein, which aims to remove the stigma of mental illness and demonstrate that with help, there is hope.

Attachments

  • Webinar Presenter
  • Webinar Host

Myrna Manners
Brain & Behavior Research Foundation
(718) 986-7255
mmanners@mannersdotson.com

More News

View More
Why the Precious Metal Nobody Talks About Could Be Your Best Bet
Today 14:43 EDT
Via MarketBeat
Topics ETFs Economy
Tickers PALL VOO
Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
Today 12:46 EDT
Via MarketBeat
Tickers CMG YUM
3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Today 11:34 EDT
Via MarketBeat
Topics Economy Stocks World Trade
Tickers CC DOW NUE
A Copper Catalyst: Why Freeport-McMoRan Is Positioned to Rebound
Today 10:44 EDT
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers BAC FCX
MarketBeat Week in Review – 09/29 - 10/03
Today 7:00 EDT
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers AAPL APP BBAI BYDDF COST CRWV
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.45
+0.02 (0.01%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap